Go to The Journal of Clinical Investigation
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
  • Physician-Scientist Development
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Immunology
    • Metabolism
    • Nephrology
    • Oncology
    • Pulmonology
    • All ...
  • Videos
  • Collections
    • In-Press Preview
    • Resource and Technical Advances
    • Clinical Research and Public Health
    • Research Letters
    • Editorials
    • Perspectives
    • Physician-Scientist Development
    • Reviews
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • In-Press Preview
  • Resource and Technical Advances
  • Clinical Research and Public Health
  • Research Letters
  • Editorials
  • Perspectives
  • Physician-Scientist Development
  • Reviews
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
Stress-enhanced cardiac lncRNA Morrbid protects hearts from acute myocardial infarction
Yang Yu, Haiqiong Yang, Qiuting Li, Nianhui Ding, Jiali Gao, Gan Qiao, Jianguo Feng, Xin Zhang, Jianming Wu, Yajun Yu, Xiangyu Zhou, Xiaobin Wang, Chunxiang Zhang
Yang Yu, Haiqiong Yang, Qiuting Li, Nianhui Ding, Jiali Gao, Gan Qiao, Jianguo Feng, Xin Zhang, Jianming Wu, Yajun Yu, Xiangyu Zhou, Xiaobin Wang, Chunxiang Zhang
View: Text | PDF
Research Article Cardiology Cell biology

Stress-enhanced cardiac lncRNA Morrbid protects hearts from acute myocardial infarction

  • Text
  • PDF
Abstract

Myeloid RNA regulator of Bim-induced death (Morrbid) is a newly identified leukocyte-specific long noncoding RNA (lncRNA). However, the expression and biological functions of Morrbid in cardiomyocytes and heart disease are currently unclear. This study was meant to determine the role of cardiac Morrbid in acute myocardial infarction (AMI) and to identify the potential cellular and molecular mechanisms involved. We found that both human and mouse cardiomyocytes could express a significant amount of Morrbid and that its expression was increased in cardiomyocytes with hypoxia or oxidative stress as well as in mouse hearts with AMI. Overexpression of Morrbid reduced the myocardial infarct size and cardiac dysfunction, whereas the infarct size and cardiac dysfunction deteriorated in cardiomyocyte-specific Morrbid-KO (Morrbidfl/fl/Myh6-Cre) mice. We identified that Morrbid had a protective effect against hypoxia- or H2O2-induced apoptosis; this was also confirmed in vivo in mouse hearts after AMI. We further discovered that serpine1 was a direct target gene of Morrbid that was involved in the Morrbid-mediated protective effect on cardiomyocytes. In summary, we have found, for the first time to our knowledge, that the cardiac Morrbid is a stress-enhanced lncRNA that protects hearts from AMI via antiapoptosis through its target gene serpine1. Morrbid may be a novel promising therapeutic target for ischemic heart diseases such as AMI.

Authors

Yang Yu, Haiqiong Yang, Qiuting Li, Nianhui Ding, Jiali Gao, Gan Qiao, Jianguo Feng, Xin Zhang, Jianming Wu, Yajun Yu, Xiangyu Zhou, Xiaobin Wang, Chunxiang Zhang

×

Figure 4

The effect of Morrbid on hypoxia-induced cardiac cell apoptosis in vitro.

Options: View larger image (or click on image) Download as PowerPoint
The effect of Morrbid on hypoxia-induced cardiac cell apoptosis in vitro...
Cultured cardiomyocyte apoptosis was induced by hypoxia for 24 hours in a serum-free and low-glucose medium. Cell apoptosis was determined by TUNEL staining. (A and B) Representative TUNEL-stained photomicrographs from cardiomyocytes treated with Ad-GFP, Ad-Morrbid, vehicle, or Morrbid siRNA. Scale bars: 100 μm. (C) Hypoxia resulted in an increase in apoptosis (P < 0.001; Ad-GFP without hypoxia, n = 6; Ad-GFP hypoxia, n = 6), and the increased apoptosis was inhibited after treatment with Ad-Morrbid (P < 0.001; Ad-Morrbid with hypoxia, n = 6; Ad-GFP with hypoxia, n = 6). (D) Cardiomyocyte apoptosis was exacerbated after treatment with Morrbid siRNA (P < 0.001; Vehicle, n = 6; Morrbid siRNA, n = 6). Red, apoptotic cell; blue, the cell nucleus stained by DAPI. ***P < 0.001 by 1-way ANOVA with Sidak’s post hoc correction for multiple comparisons (C) or unpaired 2-tailed Student’s t tests (D).

Copyright © 2026 American Society for Clinical Investigation
ISSN 2379-3708

Sign up for email alerts